LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Zurück zur letzten Suche Suchhistorie
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Prakash, Nishant"
  2. AU="Loew, Thomas"
  3. AU=Kroemer Guido
  4. AU="Bomonetto, Juliana Vieira Biason"
  5. AU="Benavides-González, Mario Alberto"
  6. AU="Matsuo, Kazuya"
  7. AU="Yaniv, Ziv"
  8. AU="Robertson, Anne"
  9. AU="Davis, Rebecca"
  10. AU="Joy, Tisha R"
  11. AU="Özil, Musa"
  12. AU="Franci, Lorenzo"
  13. AU="Khoobdel, Mehdi"
  14. AU="Ian B Wilkinson"
  15. AU="Sarpün, I.H."
  16. AU="Gums, Jeremiah J"
  17. AU="Petsalaki, Eleni"
  18. AU="Yu, Weichao"
  19. AU="Mertens, Anne Wiebke"
  20. AU="Roitershtein, Alexander"
  21. AU="Deppen, Stephen"
  22. AU="Goliath, Rene"
  23. AU="Emons, Günter"
  24. AU="Sarah S. Barnett"

Suchergebnis

Treffer 1 - 4 von insgesamt 4

Suchoptionen

  1. Artikel: SA, ABA and Pseudomonas fluorescens elicit defense responses in tomato against Alternaria blight

    Prakash, Nishant / Vishunavat, Karuna / Khan, Gohar Taj / Prasad, Pramod

    Journal of plant biochemistry and biotechnology. 2021 Mar., v. 30, no. 1

    2021  

    Abstract: Alternaria blight causes significant losses in tomato. High disease severity during fruiting stage restricts the applicability of chemicals. Chemical pesticides can be substituted by resistance inducing agents. In present investigation, two resistance ... ...

    Abstract Alternaria blight causes significant losses in tomato. High disease severity during fruiting stage restricts the applicability of chemicals. Chemical pesticides can be substituted by resistance inducing agents. In present investigation, two resistance inducing agents namely Salicylic acid and Abscisic acid and a plant growth promoting rhizobacteria Pseudomonas fluorescens strain PBAT-2 (Psf) were used to assess their effect on Alternaria blight disease severity through the activity of defense-related compounds i.e. Peroxidase (POD), Polyphenol oxidase (PPO), Phenyl ammonia lyase (PAL), total phenolic content along with pathogenesis-related gene PR-1 and β-1,3-glucanase (GLU) gene expression in tomato. SA, ABA and Psf reduced disease severity significantly as compared to control. A significant increase in the activity of POD, PPO, PAL and total phenol content was recorded in all the three treatments over control. POD, PPO, PAL levels were significantly high at 24 h and 48 h post Alternaria solani inoculation, whereas total phenolic content increased up to 72 h. The expression of PR-1 and GLU gene was upregulated at 24 h post A. solani inoculation in SA and ABA treated leaves. However, these genes were unexpressed in Psf treated plants which confirms the role of SA and ABA in systemic acquired resistance. These findings suggest that SA, ABA and Psf can be used in early blight management in tomato without affecting the quality of the fruit.
    Schlagwörter Alternaria solani ; Pseudomonas fluorescens ; abscisic acid ; ammonia ; biotechnology ; blight ; catechol oxidase ; disease severity ; fruits ; gene expression ; genes ; pathogenesis-related proteins ; peroxidase ; plant growth ; rhizosphere bacteria ; salicylic acid ; systemic acquired resistance ; tomatoes
    Sprache Englisch
    Erscheinungsverlauf 2021-03
    Umfang p. 13-25.
    Erscheinungsort Springer India
    Dokumenttyp Artikel
    Anmerkung NAL-AP-2-clean
    ZDB-ID 2206337-7
    ISSN 0974-1275 ; 0971-7811
    ISSN (online) 0974-1275
    ISSN 0971-7811
    DOI 10.1007/s13562-020-00564-x
    Datenquelle NAL Katalog (AGRICOLA)

    Volltext online

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  2. Artikel ; Online: Lp(a)-Associated Oxidized Phospholipids in Healthy Black and White Participants in Relation to apo(a) Size, Age, and Family Structure.

    Berglund, Lars / Kim, Kyoungmi / Zhang, Wei / Prakash, Nishant / Truax, Kevin / Anuurad, Erdembileg / Enkhmaa, Byambaa

    Journal of the American Heart Association

    2021  Band 10, Heft 17, Seite(n) e020158

    Abstract: Background Lp(a) (lipoprotein(a)) is the major lipoprotein carrier of oxidized phospholipids (OxPL) and this function mediates Lp(a) atherogenicity. However, the relationship between OxPL, Lp(a), and genetic and biological characteristics remains poorly ... ...

    Abstract Background Lp(a) (lipoprotein(a)) is the major lipoprotein carrier of oxidized phospholipids (OxPL) and this function mediates Lp(a) atherogenicity. However, the relationship between OxPL, Lp(a), and genetic and biological characteristics remains poorly understood. We assessed the relationship between Lp(a)-bound OxPL, apolipoprotein(a) (apo(a)) size, age, and family structure in 2 racial groups. Methods and Results Healthy Black and White families were recruited from the general population (age: 6-74 years, n=267). OxPL and Lp(a) levels were assayed enzymatically; apo(a) isoform,
    Mesh-Begriff(e) Adolescent ; Adult ; Aged ; Apoprotein(a)/genetics ; Blacks/genetics ; Child ; Humans ; Lipoprotein(a)/genetics ; Middle Aged ; Oxidation-Reduction ; Phospholipids ; Whites/genetics ; Young Adult
    Chemische Substanzen Lipoprotein(a) ; Phospholipids ; Apoprotein(a) (EC 3.4.21.-)
    Sprache Englisch
    Erscheinungsdatum 2021-08-25
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2653953-6
    ISSN 2047-9980 ; 2047-9980
    ISSN (online) 2047-9980
    ISSN 2047-9980
    DOI 10.1161/JAHA.120.020158
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  3. Artikel ; Online: Non-HDL-C levels and residual cardiovascular risk: Do population-specific precision approaches offer any advantages?

    Enkhmaa, Byambaa / Prakash, Nishant / Berglund, Lars

    Atherosclerosis

    2018  Band 274, Seite(n) 230–231

    Mesh-Begriff(e) Brazil ; Cardiovascular Diseases ; Cholesterol, HDL ; Goals ; Humans ; Risk Factors
    Chemische Substanzen Cholesterol, HDL
    Sprache Englisch
    Erscheinungsdatum 2018-05-05
    Erscheinungsland Ireland
    Dokumenttyp Editorial ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 80061-2
    ISSN 1879-1484 ; 0021-9150
    ISSN (online) 1879-1484
    ISSN 0021-9150
    DOI 10.1016/j.atherosclerosis.2018.05.010
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Volltext online

    Zusatzmaterialien

    Kategorien

    Verfügbar in ZB MED Köln/Königswinter

    Zs.A 226: Hefte anzeigen Standort:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

  4. Artikel ; Online: PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability.

    Enkhmaa, Byambaa / Kim, Kyoungmi / Zhang, Wei / Prakash, Nishant / Truax, Kevin / Anuurad, Erdembileg / Berglund, Lars

    Journal of the Endocrine Society

    2020  Band 4, Heft 7, Seite(n) bvaa073

    Abstract: Context: Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces lipoprotein(a) [Lp(a)] levels, but the association of PCSK9 with Lp(a) level and its major determinant, apolipoprotein(a) [apo(a)] size, is not fully understood.: ... ...

    Abstract Context: Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces lipoprotein(a) [Lp(a)] levels, but the association of PCSK9 with Lp(a) level and its major determinant, apolipoprotein(a) [apo(a)] size, is not fully understood.
    Objective: To assess the relationship between PCSK9, Lp(a) level, apo(a) size, age, and ethnicity/race.
    Design: Cross-sectional.
    Setting: General population.
    Participants: Healthy African Americans and Caucasians (n = 267); age range: 6 to 74 years.
    Interventions: None.
    Main outcome measures: PCSK9 levels, apo(a) isoform and
    Results: Plasma PCSK9 levels were significantly higher in African Americans vs Caucasians, in females vs males, and in adults vs children. PCSK9 levels were not associated with total plasma Lp(a) levels either in all participants or in ethnicity-specific analyses. However, PCSK9 levels were significantly positively associated with isoform-specific Lp(a) levels carried by the larger apo(a) size in all participants (
    Conclusions: Among African Americans, but not Caucasians, PCSK9 levels were associated with isoform-specific Lp(a) levels carried on larger, but not smaller, apo(a) sizes. The findings illustrate a diverging relationship of PCSK9 with isoform-specific Lp(a) levels across ethnicity.
    Sprache Englisch
    Erscheinungsdatum 2020-06-11
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 2472-1972
    ISSN (online) 2472-1972
    DOI 10.1210/jendso/bvaa073
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

    Über subito bestellen

    Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.

    Fernleihe an ZB MED

    Sie können sich den gewünschten Titel als lokale Nutzerin oder lokaler Nutzer von ZB MED direkt an den Standort Köln schicken lassen.

Zum Seitenanfang